These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36694463)

  • 1. Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage.
    Li F; Ichinose K; Ishibashi S; Yamamoto S; Iwasawa E; Suzuki M; Yoshida-Tanaka K; Yoshioka K; Nagata T; Hirabayashi H; Mogushi K; Yokota T
    Mol Ther; 2023 Apr; 31(4):1106-1122. PubMed ID: 36694463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice.
    Suzuki M; Ishibashi S; Iwasawa E; Oguma T; Saito Y; Li F; Otsu S; Ichinose K; Yoshioka K; Nagata T; Yokota T
    Sci Rep; 2021 Jul; 11(1):14237. PubMed ID: 34244578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo.
    Kuwahara H; Song J; Shimoura T; Yoshida-Tanaka K; Mizuno T; Mochizuki T; Zeniya S; Li F; Nishina K; Nagata T; Ito S; Kusuhara H; Yokota T
    Sci Rep; 2018 Mar; 8(1):4377. PubMed ID: 29531265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Model Analysis and Simulation of Pharmacokinetics and
    Goto A; Yamamoto S; Igari T; Matsumoto SI; Chisaki I; Iida K; Nakayama M; Oda A; Kakoi Y; Uchida A; Miyata K; Nishikawa M; Nagata T; Kusuhara H; Yokota T; Hirabayashi H
    J Pharmacol Exp Ther; 2023 Jan; 384(1):197-204. PubMed ID: 36273821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
    Asada K; Sakaue F; Nagata T; Zhang JC; Yoshida-Tanaka K; Abe A; Nawa M; Nishina K; Yokota T
    Nucleic Acids Res; 2021 May; 49(9):4864-4876. PubMed ID: 33928345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides.
    Nishi R; Ohyagi M; Nagata T; Mabuchi Y; Yokota T
    Mol Ther; 2022 Jun; 30(6):2210-2223. PubMed ID: 35189344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo.
    Asami Y; Nagata T; Yoshioka K; Kunieda T; Yoshida-Tanaka K; Bennett CF; Seth PP; Yokota T
    Mol Ther; 2021 Feb; 29(2):838-847. PubMed ID: 33290725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.
    Nishina K; Piao W; Yoshida-Tanaka K; Sujino Y; Nishina T; Yamamoto T; Nitta K; Yoshioka K; Kuwahara H; Yasuhara H; Baba T; Ono F; Miyata K; Miyake K; Seth PP; Low A; Yoshida M; Bennett CF; Kataoka K; Mizusawa H; Obika S; Yokota T
    Nat Commun; 2015 Aug; 6():7969. PubMed ID: 26258894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient silencing of microRNA by heteroduplex oligonucleotides.
    Yoshioka K; Kunieda T; Asami Y; Guo H; Miyata H; Yoshida-Tanaka K; Sujino Y; Piao W; Kuwahara H; Nishina K; Hara RI; Nagata T; Wada T; Obika S; Yokota T
    Nucleic Acids Res; 2019 Aug; 47(14):7321-7332. PubMed ID: 31214713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-targeted intranasal delivery of protein-based gene therapy for treatment of ischemic stroke.
    Ryu JY; Cerecedo-Lopez C; Yang H; Ryu I; Du R
    Theranostics; 2024; 14(12):4773-4786. PubMed ID: 39239521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.
    Zeniya S; Kuwahara H; Daizo K; Watari A; Kondoh M; Yoshida-Tanaka K; Kaburagi H; Asada K; Nagata T; Nagahama M; Yagi K; Yokota T
    J Control Release; 2018 Aug; 283():126-134. PubMed ID: 29753959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model.
    Kim M; Lee Y; Lee M
    Nanoscale; 2021 Sep; 13(33):14166-14178. PubMed ID: 34477698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo.
    Ohyagi M; Nagata T; Ihara K; Yoshida-Tanaka K; Nishi R; Miyata H; Abe A; Mabuchi Y; Akazawa C; Yokota T
    Nat Commun; 2021 Dec; 12(1):7344. PubMed ID: 34937876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery system of therapeutic oligonucleotides.
    Asami Y; Yoshioka K; Nishina K; Nagata T; Yokota T
    Drug Discov Ther; 2016; 10(5):256-262. PubMed ID: 27890899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve.
    Kaburagi H; Nagata T; Enomoto M; Hirai T; Ohyagi M; Ihara K; Yoshida-Tanaka K; Ebihara S; Asada K; Yokoyama H; Okawa A; Yokota T
    Mol Ther Nucleic Acids; 2022 Jun; 28():910-919. PubMed ID: 35694210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycocalyx is critical for blood-brain barrier integrity by suppressing caveolin1-dependent endothelial transcytosis following ischemic stroke.
    Zhu J; Li Z; Ji Z; Wu Y; He Y; Liu K; Chang Y; Peng Y; Lin Z; Wang S; Wang D; Huang K; Pan S
    Brain Pathol; 2022 Jan; 32(1):e13006. PubMed ID: 34286899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function.
    Huang L; Liu Y; Lu J; Cerqueira B; Misra V; Duong TQ
    Stem Cell Res Ther; 2017 Mar; 8(1):74. PubMed ID: 28330501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells.
    Sousa de Almeida M; Rothen-Rutishauser B; Mayer M; Taskova M
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation-related rapid nuclear transport of DNA/RNA heteroduplex oligonucleotide: unveiling distinctive intracellular trafficking.
    Ono D; Asada K; Yui D; Sakaue F; Yoshioka K; Nagata T; Yokota T
    Mol Ther Nucleic Acids; 2021 Mar; 23():1360-1370. PubMed ID: 33738132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.